Insiders · Profile

Hopman Mark

Chief Commercial Officer at Beta Bionics. Filing since 2 Jun 2025. CIK 0002048497

Company

Date

Role

Action

Shares

Amount

Of holding

BBNX Beta Bionics, Inc.

1 Oct 2026

Chief Commercial Officer

Sold at will

370

$7.02K

0.7%

BBNX Beta Bionics, Inc.

16 Sep 2026

Chief Commercial Officer

Sold on a plan

30,779

$619.64K

35.3%

BBNX Beta Bionics, Inc.

14 Sep 2026

Chief Commercial Officer

Sold on a plan

775

$12.03K

0.9%

BBNX Beta Bionics, Inc.

9 Sep 2026

Chief Commercial Officer

Sold on a plan

36,870

$680.72K

29.7%

BBNX Beta Bionics, Inc.

2 Sep 2026

Chief Commercial Officer

Sold at will

5,327

$101.82K

4.1%

BBNX Beta Bionics, Inc.

24 Jun 2026

Chief Commercial Officer

Sold on a plan

1,258

$18.88K

1.0%

BBNX Beta Bionics, Inc.

4 Jun 2026

Chief Commercial Officer

Sold on a plan

275

$3.39K

0.2%

BBNX Beta Bionics, Inc.

2 Jun 2026

Chief Commercial Officer

Sold at will

5,329

$67.18K

3.9%

BBNX Beta Bionics, Inc.

4 Mar 2026

Chief Commercial Officer

Sold on a plan

353

$4.08K

0.3%

BBNX Beta Bionics, Inc.

2 Mar 2026

Chief Commercial Officer

Sold at will

834

$10.31K

0.6%

BBNX Beta Bionics, Inc.

4 Dec 2025

Chief Commercial Officer

Sold on a plan

2,061

$63.19K

1.5%

BBNX Beta Bionics, Inc.

2 Dec 2025

Chief Commercial Officer

Sold on a plan

856

$25.11K

0.6%

BBNX Beta Bionics, Inc.

5 Sep 2025

Chief Commercial Officer

Sold on a plan

11,411

$234.66K

26.8%

BBNX Beta Bionics, Inc.

4 Sep 2025

Chief Commercial Officer

Sold on a plan

6,818

$136.18K

17.9%

BBNX Beta Bionics, Inc.

2 Sep 2025

Chief Commercial Officer

Sold at will

848

$16.00K

2.5%

BBNX Beta Bionics, Inc.

19 Aug 2025

Chief Commercial Officer

Sold on a plan

16,158

$268.38K

32.1%

BBNX Beta Bionics, Inc.

2 Jun 2025

Chief Commercial Officer

Sold at will

868

$15.53K

2.5%

17 decisions on file.